Delee Corp

Delee is a medical device company that has developed two devices: the CytoCatchTM Isolation Platform and the CytoCatchTM Imaging System, for isolating and analyzing circulating tumor cells (CTCs) from patient blood samples. The isolation platform filters CTCs onto a membrane and stains them through an automated workflow for visualization, and analysis via the imaging system. This technology will help in the early detection of cancer while providing physicians with information to personalize each patients therapy and monitor its effectiveness throughout the course of their disease

Circulating tumor cells,liquid biopsy,ctc,medical device,medical device oncology,cancer diagnostics,molecular analysis,ctc analysis,cancer cells,medical research,and biotechnology

Delee corp operates in the Biotechnology research industry.

Delee corp's revenue is 11m - 100m

Delee corp has 11 - 50 employees.